Δημοσιεύσεις

  1. Kyritsis AP, Markoula S, Alexiou G, Asimakopoulos A, Jabbour P, Fotopoulos A, Sioka C. Diagnosis and treatment of limbic encephalitis in the cancer patient. Future Oncol. 2020 Aug;16(22):1647-1655.
  2. Nikas IP, Themistocleous SC, Paschou SA, Tsamis KI, Ryu HS. Serine-Arginine Protein Kinase 1 (SRPK1) as a Prognostic Factor and Potential Therapeutic Target in Cancer: Current Evidence and Future Perspectives. Cells. 2019 Dec 19;9(1):19.
  3. Alexiou GA, Vartholomatos G, Kobayashi T, Voulgaris S, Kyritsis AP. The emerging role of intraoperative flow cytometry in intracranial tumor surgery. Clin Neurol Neurosurg. 2020 May;192:105742
  4. Nikas IP, Themistocleous SC, Paschou SA, Tsamis KI, Ryu HS. Serine-Arginine Protein Kinase 1 (SRPK1) as a Prognostic Factor and Potential Therapeutic Target in Cancer: Current Evidence and Future Perspectives. Cells. 2019 Dec 19;9(1):19.
  5. Vartholomatos E, Alexiou GA, Markopoulos GS, Lazari D, Tsiftsoglou O, Chousidis I, Leonardos I, Kyritsis AP. Deglucohellebrin: A Potent Agent for Glioblastoma Treatment. Anticancer Agents Med Chem. 2020;20(1):103-110.
  6. Alexiou GA, Vartholomatos G, Voulgaris S, Kyritsis AP. Letter to the Editor Regarding “Fluorescein Sodium in Surgical Treatment of Recurrent Glioblastoma Multiforme”. World Neurosurg. 2019 Aug;128:616.
  7. Paschou SA, Tsamis KI, Kanaka-Gantenbein C, Johnson EO, Chrousos GP. Neurobehavioral and neuroendocrine regulation of energy homeostasis. Postgrad Med. 2019 Sep;131(7):413-414.
  8. Katsanos AH, Alexiou GA, Fotopoulos AD, Jabbour P, Kyritsis AP, Sioka C. Performance of 18F-FDG, 11C-Methionine, and 18F-FET PET for Glioma Grading: A Meta-analysis. Clin Nucl Med. 2019 Nov;44(11):864-869.
  9. Alexiou GA, Vartholomatos G, Stefanaki K, Markopoulos GS, Kyritsis AP. Intraoperative Flow Cytometry for Diagnosis of Central Nervous System Lesions. J Cytol. 2019 Apr-Jun;36(2):134-135.
  10. Alexiou GA, Vartholomatos E, I Tsamis K, Peponi E, Markopoulos G, A Papathanasopoulou V, Tasiou I, Ragos V, Tsekeris P, Kyritsis AP, Galani V. Combination treatment for glioblastoma with temozolomide, DFMO and radiation. J BUON. 2019 Jan-Feb;24(1):397-404.
  11. Nikas IP, Themistocleous SC, Paschou SA, Tsamis KI, Ryu HS. Serine-Arginine Protein Kinase 1 (SRPK1) as a Prognostic Factor and Potential Therapeutic Target in Cancer: Current Evidence and Future Perspectives. Cells. 2019 Dec 19;9(1):19.
  12. Katsanos AH, Sioka C, Chondrogiorgi M, Papadopoulos A, Fotopoulos A, Kyritsis AP, Ragos V. Skull Base Metastasis Revealed by Bone Scintigraphy in a Patient With Hypoglossal Nerve Palsy.Neurohospitalist. 2018 Oct;8(4):188-190. doi: 10.1177/1941874418755952.Epub 2018 Feb 13. PubMed PMID: 30245769; PubMed Central PMCID: PMC6146351.
  13. Vartholomatos G, Alexiou GA, Voulgaris S, Kyritsis AP. Intraoperative Immunophenotypic Analysis for Diagnosis and Classification of Primary Central Nervous System Lymphomas.World Neurosurg. 2018 Sep;117:464-465. doi:10.1016/j.wneu.2018.03.022. PubMed PMID: 30149427.
  14. Vartholomatos G, Alexiou GA, Lianos GD, Harissis H, Voulgaris S, Kyritsis AP. Intraoperative cell cycle analysis for tumor margins evaluation: The future is now? Int J Surg. 2018 May;53:380-381. doi: 10.1016/j.ijsu.2018.03.046. Epub 2018 Mar 29. PubMed PMID: 29605577.
  15. Mitsis M, Alexiou GA, Vartholomatos E, Markopoulos G, Lazari D, Hodaj E, Nastos D, Zagorianakou P, Galani V, Kyritsis AP. N-(p-coumaroyl) serotonin induces cell cycle arrest and apoptosis in breast cancer cells. J BUON. 2018 Jan-Feb;23(1):129-133.
  16. Mitsis M, Markopoulos G,Alexiou GA, Vartholomatos E, Lazari D, Hodaj E, Nastos D, Zagorianakou P, Galani V, Kyritsis AP.Antiproliferative and cytotoxic action of N-(p-coumaroyl) serotonin in lung cancer cells. JBUON (in press)
  17. Giannopoulos S, Markoula S, Sioka C, Zouroudi S, Spiliotopoulou M, Naka KK, Michalis LK, Fotopoulos A, Kyritsis AP. Detecting Myocardial Ischemia With(99m)Technetium-Tetrofosmin Myocardial Perfusion Imaging in Ischemic Stroke. Neurohospitalist. 2017 Oct;7(4):164-168. doi: 10.1177/1941874417704752. Epub 2017 Apr 18. PubMed PMID: 28974994; PubMed Central PMCID: PMC5613870.
  18. Katsanos AH, Kosmidou M, Konitsiotis S, Tsivgoulis G, Fiolaki A, Kyritsis AP, Giannopoulos S. Restless legs syndrome and cerebrovascular/cardiovascular events: Systematic review and meta-analysis.ActaNeurol Scand. 2018 Jan;137(1):142-148. doi: 10.1111/ane.12848. Epub 2017 Sep 25. Review. PubMed PMID: 28948600.
  19. Georgakis MK, Papathoma P, Ryzhov A, Zivkovic-Perisic S, Eser S, Taraszkiewicz Georgakis MK, Papathoma P, Ryzhov A, Zivkovic-Perisic S, Eser S, Taraszkiewicz Ł, Sekerija M, Žagar T, Antunes L, Zborovskaya A, Bastos J, Florea M, Coza D, Demetriou A, Agius D, Strahinja RM, Themistocleous M, Tolia M, Tzanis S, Alexiou GA, Papanikolaou PG, Nomikos P, Kantzanou M, Dessypris N, Pourtsidis A, Petridou ET. Malignant central nervous system tumors among adolescents and young adults (15-39 years old) in 14 Southern-Eastern European registries and the US Surveillance, Epidemiology, and End Results program: Mortality and survival patterns. Cancer. 2017 Nov 15;123(22):4458-4471. doi: 10.1002/cncr.30884. Epub 2017 Jul 14. PubMed PMID: 28708937.
  20. Galani V, Lampri E, Varouktsi A, Alexiou G, Mitselou A, Kyritsis AP. Genetic and epigenetic alterations in meningiomas. ClinNeurolNeurosurg. 2017 Jul;158:119-125. doi: 10.1016/j.clineuro.2017.05.002. Epub 2017 May 3. Review. PubMed PMID: 28527972.
  21. Alexiou GA, Lazari D, Markopoulos G, Vartholomatos E, Hodaj E, Galani V, Kyritsis AP. Moschamine inhibits proliferation of glioblastoma cells via cell cycle arrest and apoptosis. Tumour Biol. 2017 May;39(5):1010428317705744. doi: 10.1177/1010428317705744. PubMed PMID: 28475011.
  22. Alexiou GA, Vartholomatos G, Markopoulos GS, Voulgaris S, Kyritsis AP. Effectiveness of flow cytometry for brain tumor excision.PhotodiagnosisPhotodyn Ther. 2017 Jun;18:323-324. doi: 10.1016/j.pdpdt.2017.04.016. Epub 2017 Apr 27. PubMed PMID: 28457850.
  23. Fiolaki A, Katsanos AH, Kyritsis AP, Papadaki S, Kosmidou M, Moschonas IC, Tselepis AD, Giannopoulos S. High on treatment platelet reactivity to aspirin and clopidogrel in ischemic stroke: A systematic review and meta-analysis. J Neurol Sci. 2017 May 15;376:112-116.
  24. Galani V, Papadatos SS, Alexiou G, Galani A, Kyritsis AP. In Vitro and In Vivo Preclinical Effects of Type I IFNs on Gliomas. J Interferon Cytokine Res. 2017 Apr;37(4):139-146. doi: 10.1089/jir.2016.0094. Epub 2017 Feb 17. Review. PubMed PMID: 28387596.
  25. Lazari D, Alexiou GA, Markopoulos GS, Vartholomatos E, Hodaj E, Chousidis I, Leonardos I, Galani V, Kyritsis AP. N-(p-coumaroyl) serotonin inhibits glioblastoma cells growth through triggering S-phase arrest and apoptosis. J Neurooncol. 2017 May;132(3):373-381. doi: 10.1007/s11060-017-2382-3. Epub 2017 Apr 1. PubMed PMID: 28365838.
  26. Alexiou GA, Xourgia X, Gerogianni P, Vartholomatos E, Kalef-Ezra JA, Fotopoulos AD, Kyritsis AP. (99m)Tc-Tetrofosmin Uptake Correlates with the Sensitivity of Glioblastoma Cell Lines to Temozolomide. World J Nucl Med. 2017 Jan-Mar;16(1):45-50. doi: 10.4103/1450-1147.181155. PubMed PMID: 28217019; PubMed Central PMCID: PMC5314663.
  27. Alexiou GA, Lianos GD, Ragos V, Galani V, Kyritsis AP. Difluoromethylornithine in cancer: new advances. Future Oncol. 2017 Apr;13(9):809-819. doi: 10.2217/fon-2016-0266. Epub 2017 Jan 27. Review. PubMed PMID: 28125906.
  28. Kosmidou M, Katsanos AH, Katsanos KH, Kyritsis AP, Tsivgoulis G, Christodoulou D, Giannopoulos S. Multiple sclerosis and inflammatory bowel diseases: a systematic review and meta-analysis. J Neurol. 2017 Feb;264(2):254-259. doi: 10.1007/s00415-016-8340-8. Epub 2016 Nov 22. Review. PubMed PMID: 27878439.
  29. Vartholomatos G, Alexiou GA, Lianos GD, Kyritsis AP. From bench to operating theater: has the time come for a molecular scalpel? Future Oncol. 2017 Jan;13(2):121-123. Epub 2016 Nov 4. PubMed PMID: 27809605.
  30. Alexiou GA, Gerogianni P, Vartholomatos E, Kyritsis AP. Deferiprone Enhances Temozolomide Cytotoxicity in Glioma Cells. Cancer Invest. 2016 Nov 25;34(10):489-495. Epub 2016 Oct 21. PubMed PMID: 27768402.
  31. Sigala I, Tsamis KI, Gousia A, Alexiou G, Voulgaris S, Giannakouros T, Kyritsis AP, Nikolakaki E. Expression of SRPK1 in gliomas and its role in glioma cell lines viability. Tumour Biol. 2016 Jul;37(7):8699-707. doi: 10.1007/s13277-015-4738-7.Epub 2016 Jan 6. PubMed PMID: 26738865.
  32. Katsanos AH, Fiolaki A, Markou S, Markoula S, Kosmidou M, Kyritsis AP, Giannopoulos S. Ischemic stroke risk factors during Greek economic crisis. Atherosclerosis. 2016 Feb;245:118-22. doi: 10.1016/j.atherosclerosis.2015.12.013. Epub 2015 Dec 9. PubMed PMID: 26717274.
  33. Katsanos AH, Patsouras D, Tsivgoulis G, Kosmidou M, Katsanos KH, Kyritsis AP, Giannopoulos S. The value of transesophageal echocardiography in the investigation and management of cryptogenic cerebral ischemia: a single-center experience. Neurol Sci. 2016 Apr;37(4):629-32. doi: 10.1007/s10072-015-2448-y. Epub 2015 Dec 24. PubMed PMID: 26705252.
  34. Alexiou GA, Sioka C. Mobile phone use and risk for intracranial tumors. J Negat Results Biomed. 2015 Dec 23;14:23. doi: 10.1186/s12952-015-0043-7. Review. PubMed PMID: 26699288; PubMed Central PMCID: PMC4690283.
  35. Sioka C, Fotopoulos A, Papakonstantinou S, Georgiou A, Pelidou SH, Kyritsis AP, Kalef-Ezra JA. The effect of menarche age, parity and lactation on bone mineral density in premenopausal ambulatory multiple sclerosis patients. Mult SclerRelatDisord. 2015 Jul;4(4):287-90. doi: 10.1016/j.msard.2015.05.006. Epub 2015 May 21. PubMed PMID: 26195044.
  36. Alexiou GA, Tsamis KI, Kyritsis AP. Targeting Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL): A Promising Therapeutic Strategy in Gliomas. SeminPediatr Neurol. 2015 Mar;22(1):35-9. doi: 10.1016/j.spen.2014.12.002. Epub 2014 Dec 11.Review. PubMed PMID: 25976259.
  37. Alexiou GA, Tsamis KI, Vartholomatos E, Peponi E, Tzima E, Tasiou I, Lykoudis E, Tsekeris P, Kyritsis AP. Combination treatment of TRAIL, DFMO and radiation for malignant glioma cells. J Neurooncol. 2015 Jun;123(2):217-24. doi: 10.1007/s11060-015-1799-9.Epub 2015 May 3. PubMed PMID: 25935110.
  38. Sioka C, Assimakopoulos A, Fotopoulos A. The diagnostic role of (18)F fluorodeoxyglucose positron emission tomography in patients with fever of unknown origin. Eur J Clin Invest. 2015 Jun;45(6):601-8. doi: 10.1111/eci.12439. Epub 2015 Apr 24.Review. PubMed PMID: 25823953.
  39. Vartholomatos G, Alexiou GA, Gerogianni P, Lykoudis E, Voulgaris S, Kyritsis Is there a role for intraoperative flow cytometry in brain tumor surgery? Cytometry B ClinCytom. 2015 Sep-Oct;88(5):289-90. doi: 10.1002/cyto.b.21235. PubMed PMID: 25728803.
  40. Alexiou GA, Xourgia X, Vartholomatos E, Tsiouris S, Kalef-Ezra JA, Fotopoulos AD, Kyritsis AP. Comparison of (99m)tc-tetrofosmin and (99m)tc-sestamibi uptake inglioma cell lines: the role of p-glycoprotein expression. Int J Mol Imaging. 2014;2014:471032.
  41. Alexiou GA, Vartholomatos G, Goussia A, Batistatou A, Tsamis K, Voulgaris S,  Kyritsis AP. Fast cell cycle analysis for intraoperative characterization of brain tumor margins and malignancy. J ClinNeurosci. 2015 Jan;22(1):129-32. doi: 10.1016/j.jocn.2014.05.029. Epub 2014 Aug 12. PubMed PMID: 25124644.
  42. Vartholomatos G, Alexiou G, Batistatou A, Kyritsis AP. Intraoperative cell-cycle analysis to guide brain tumor removal. ProcNatlAcadSci U S A. 2014 Sep 9;111(36):E3755. doi: 10.1073/pnas.1413155111. Epub 2014 Aug 13. PubMed PMID: 25122680; PubMed Central PMCID: PMC4246950.
  43. Sioka C, Fotopoulos A, Kyritsis AP. Paraneoplastic immune-mediated neurological effects of systemic cancers. Expert Rev ClinImmunol. 2014 May;10(5):621-30. doi: 10.1586/1744666X.2014.901151. Epub 2014 Mar 26. Review. PubMed PMID: 24665890.
  44. Chatzistefanidis D, Giannopoulos S, Spengos K, Vassilopoulou S, Vemmos K, Dova L, Vartholomatos G, Kyritsis AP, Georgiou I, Markoula S. Apolipoprotein E polymorphisms and ischaemic stroke: a two-center Greek study. Eur J Neurol. 2014 Aug;21(8):1083-1088. doi: 10.1111/ene.12365. Epub 2014 Jan 28. PubMed PMID: 24471738.
  45. Tsamis KI, Alexiou GA, Vartholomatos E, Kyritsis AP. Combination treatment for glioblastoma cells with tumor necrosis factor-related apoptosis-inducing ligand and oncolytic adenovirus delta-24. Cancer Invest. 2013 Nov;31(9):630-8. doi: 10.3109/07357907.2013.849724. PubMed PMID: 24164301.
  46. Sioka C. The utility of FDG PET in diagnosis and follow-up of lymphoma in childhood. Eur J Pediatr. 2013 Jun;172(6):733-8. doi: 10.1007/s00431-013-1993-8. Epub 2013 Apr 5. Review. PubMed PMID: 23559330.
  47. Pahatouridis D, Alexiou GA, Fotakopoulos G, Mihos E, Zigouris A, Drosos D, Voulgaris S. Chronic subdural haematomas: a comparative study of an enlarged single burr hole versus double burr hole drainage. Neurosurg Rev. 2013 Jan;36(1):151-4; discussion 154-5. doi: 10.1007/s10143-012-0412-3. Epub 2012 Aug PubMed PMID: 22869256.
  48. Kyritsis AP, Markoula S, Levin VA. A systematic approach to the management of patients with brain metastases of known or unknown primary site. Cancer Chemother Pharmacol. 2012 Jan;69(1):1-13. doi: 10.1007/s00280-011-1775-9. Epub 2011 Nov 1. Review. PubMed PMID: 22042515.
  49. Mitlianga PG, Sioka C, Vartholomatos G, Goussia A, Polyzoidis K, Rao JS, Kyritsis AP. p53 enhances the Delta-24 conditionally replicative adenovirus anti-glioma effect. Oncol Rep. 2006 Jan;15(1):149-53.